久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Deals this week: Innoviva, Seattle Genetics, PlasmaGen BioSciences

pharmaceutical-technologyAugust 04, 2017

Tag: Innoviva , Seattle Genetics , PlasmaGen BioSciences

US-based small molecule medicines provider Innoviva (formerly Advanced Medicine) has announced a private placement of convertible senior notes due 2025 to raise $175m.

Biotechnology company Seattle Genetics plans to acquire biopharmaceutical firm Bristol-Myers Squibb’s pharmaceutical manufacturing facility located in Bothell, Washington, US.

"Biotechnology company Seattle Genetics plans to acquire biopharmaceutical firm Bristol-Myers Squibb’s pharmaceutical manufacturing facility located in Bothell, Washington, US."

The acquisition will help the company to expand its antibody drug conjugate and immuno-oncology pipeline.

PlasmaGen BioSciences Private has secured $25m through a venture financing round led by Eight Roads Ventures India.

The Indian biopharmaceutical company will use the funds for the expansion of its product portfolio.

Previous:Latest Progress of PD-1 Inhibitors: Keytruda and Opdivo are close

Next:QS Pharma receives approval from European Medicines Agency

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service